Summary
We describe postmortem findings in a patient with human T lymphotropic virus type I (HTLV-I)-as-sociated myelopathy (HAM). The patient developed the disease 8 years after blood transfusion and showed good response to corticosteroid treatment but died of cardiac failure. Histologically, chronic, mild meningoence-phalomyelitis was noted predominantly involving the bilateral lateral and anterior columns of the middle to lower thoracic segments. The spinal cord lesions showed obvious loss of myelinated nerve fibers and fibrillary gliosis with minimal inflammatory cell infiltration. Electron microscopy of the lesion revealed disintegration of the myelin sheaths, regular separation of the minor dense line of the myelin sheaths, and completely demyelinated axons. In addition, remyelinated fibers with thin central myelin sheaths and disproportionately large axons were seen frequently. These findings indicate that primary demyelination and remyelination by oligodendrocytes occur in the spinal cord lesions of HAM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akizuki S, Setoguchi M, Nakazato O, Yoshida S, Higuchi Y, Yamamoto S, Okajima T (1988) An autopsy case of human T-lymphotropic virus type I-associated myelopathy. Hum Pathol 19:988–990
Akizuki S, Yoshida S, Setoguchi M, Higuchi Y, Yamamoto S, Nakazato O, Okajima T (1989) The neuropathology of human T-lymphotropic virus type I-associated myelopathy. In: Roman GC, Vernant JC, Osame M (eds) HTLV-I and the nervous system. Alan R. Liss, New York, pp 253–260
Allen IV (1984) Demyelinating disease. In: Adams JH, Corsellis JAN, Duchen LW (eds) Greenfield's neuropathology, 4th edn. Edward Arnold, London, pp 338–384
Bornstein MB, Raine CS (1976) The initial structural lesion in serum-induced demyelination in vitro. Lab Invest 35:391–401
Furuzono H, Nakazato O, Goto K, Akizuki S, Okajima T (1989) An autopsy case of HTLV-I associated myelopathy (HAM). Clin Neurol 29:349–354
Grundke-Iqbal I, Raine CS, Johnson AB, Brosnan CF, Bornstein MB (1981) Experimental allergic encephalomyelitis. Characterization of serum factors causing demyelination and swelling of myelin. J Neurol Sci 50:63–79
Hirano A, Cook SD, Whitaker JN, Dowling PC, Murray MR (1971) Fine structural aspects of demyelination in vitro. The effects of guillain-Barré serum. J Neuropathol Exp Neurol 30:249–265
Hsu SM, Raine L, Fanger H (1981) Use of avidine-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29:577–580
Izumo S (1989) The pathogenesis of HTLV-I associated myelopathy. Saishin Igaku 44:1603–1609
Izumo S, Usuku K, Osame M, Machigashira K, Johnosono M, Nakagawa M (1989) The neuropathology of HTLV-I-associated myelopathy in Japan: report of an autopsy case and review of the literature In: Roman GC, Vernant JC, Osame M (eds) HTLV-I and the nervous system. Alan. R. Liss, New York, pp 261–267
Johnson AB, Raine CS, Bornstein MB (1979) Experimental allergic encephalomyelitis: serum immunoglobulin binds to myelin and oligodendrocytes in cultured tissue. Ultrastructural-immunoperoxidase observations. Lab Invest 40:568–575
Kobayashi I, Ota K, Yamato K, Murakami H, Maruyama S (1989) An autopsy case of HTLV-I-associated myelopathy (HAM). Neurol Med Chir (Tokyo) 30:409–412
Lampert P, Carpenter S (1965) Electron microscopic studies on the vascular permeability and the mechanism of demyelination in experimental allergic encephalomyelitis. J Neurpathol Exp Neurol 24:11–24
Lampert P, Garrett R, Powell H (1977) Demyelination in allergic and Marek's disease virus induced neuritis. Comparative electron microscopic studies. Acta Neuropathol (Berl) 40:103–110
Liversedge LA, Rawson MD (1966) Myelopathy in hepatic disease and portosystemic venous anastomosis. Lancet I:277–279
Mendell JR, Sahenk Z, Whitaker JN, Tropp BD, Yates AJ, Griggs RC, Quarles RH (1985) Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of antimyelin-associated glycoprotein antibody. Ann Neurol 17:243–254
Moore GRW, Traugott U, Scheinberg LC, Raine CS (1989) Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol 26: 523–530
PE, Horoupian DS, Goldman JE, Hess MA (1984) Cytoptasmic filaments of Crooke's hyaline change belong to the cytokeratin class. Am J Pathol 116:214–222
Okuda K, Nakashima T Okudaira M (1982) Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. Liver 2:176–192
{au{fnOsame} {gnM}}, {au{fnUsuku} {gnK}}, {au{fnIjichi} {gnN}}, {au{fnAmitani} {gnH}}, {au{fnIgata} {gnA}}, {au{fnMatsumoto} {gnM}}, {atHTLV-1 associated myelopathy, a new climical}. {jtLancet} {vnI}:{pp1031-1032}
Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A (1987) Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol 21:117–122
Osame M, Igata A, Matsumoto M (1989) HTLV-I-associated myelopathy (HMA) revisited. In: Roman GC, Vernant JC, Osame M (eds) HTLV-I and the nervous system. Alan R. Liss, New York, pp 213–223
Pant SS, Rebeiz JJ, Richardson EP (1968) Spastic paraparesis following portacaval shunts. Neurology 18:134–141
Powell HC, Rodriguez M, Hughes RAC (1984) Microangiopathy of vasa nervorum in dysglobulinemic neuropathy. Ann Neurol 15:386–394
Propp RP, Means E, Deibel R, Sherer G, Barron K (1975) Waldenström's macroglobulinemia and neuropathy. Neurology 25:980–988
Raine CS (1985) Oligodendrocytes and central nervous system myelin. In: Davis RL, Robertson DM (eds) Textbook of neuropathology. Williams & Wilkins, Baltimore pp 92–116
Raine CS, Bornstein MB (1979) Experimental allergic neuritis. Ultrastructure of serum-induced myelin aberrations in peripheral nervous system cultures. Lab Invest 40:423–432
Roman GC (1989) Tropical spastic paraparesis and HTLV-I myelitis. Handb Clin Neurol 56:525–542
Saida K, Saida T, Brown MJ, Silberberg DH, Asburg AK (1978) Antiserum-mediated demyelination in vivo. A sequential study using intraneural injection of experimental allergic neuritis serum. Lab Invest 39:449–462
Scobie BA, Summerskill WHJ (1964) Permanent paraplegia with cirrhosis. Arch Intern Med 113:805–810
Smith IS, Kahn SN, Lacey BW, King RHM, Eames RA, Whybrew DJ, Thomas PK (1983) Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. Brain 106:169–195
Vollmer R, Weiss R (1980) Hepatische Encephalomyelopathie. In: Reisner H, Schnaberth G (eds) Fortschritte der technischen Medizin in der neurologischen Diagnostik und Therapie. Hogrefe and Huber, Stuttgart, pp 535–538
Author information
Authors and Affiliations
Additional information
Supported in part by a Grant (4-63A) from the National Center of Neurology and Psychiatry (NCNP) of the Ministry of Health and Welfare, Japan
Rights and permissions
About this article
Cite this article
Ohama, E., Horikawa, Y., Shimizu, T. et al. Demyelination and remyelination in spinal cord lesions of human lymphotropic virus type I-associated myelopathy. Acta Neuropathol 81, 78–83 (1990). https://doi.org/10.1007/BF00662641
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00662641